0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antithrombogenic Heparin Coating Market Research Report 2024
Published Date: December 2024
|
Report Code: QYRE-Auto-19L18828
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Antithrombogenic Heparin Coating Market Research Report 2024
BUY CHAPTERS

Global Antithrombogenic Heparin Coating Market Research Report 2024

Code: QYRE-Auto-19L18828
Report
December 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antithrombogenic Heparin Coating Market Size

The global market for Antithrombogenic Heparin Coating was valued at US$ 142 million in the year 2023 and is projected to reach a revised size of US$ 261 million by 2030, growing at a CAGR of 9.2% during the forecast period.

Antithrombogenic Heparin Coating Market

Antithrombogenic Heparin Coating Market

Antithrombogenic heparin coating refers to a layer of heparin that is applied to the surface of medical devices. Heparin is a glycosaminoglycan with a high negative charge density. It is a natural anticoagulant substance that can prevent blood from clotting. The heparin used in coatings usually has a certain purity and molecular weight range to ensure its anticoagulant effect.
North American market for Antithrombogenic Heparin Coating is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antithrombogenic Heparin Coating is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Antithrombogenic Heparin Coating include Carmeda AB (Gore), Biointeractions, Medtronic, Surmodics, Corline, Toyobo, jMedtech, Biosurf, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antithrombogenic Heparin Coating, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antithrombogenic Heparin Coating.
The Antithrombogenic Heparin Coating market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antithrombogenic Heparin Coating market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antithrombogenic Heparin Coating manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Antithrombogenic Heparin Coating Market Report

Report Metric Details
Report Name Antithrombogenic Heparin Coating Market
Accounted market size in year US$ 142 million
Forecasted market size in 2030 US$ 261 million
CAGR 9.2%
Base Year year
Forecasted years 2025 - 2030
by Type
  • Covalently Bonded Coatings
  • Physisorption Coatings
by Application
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Carmeda AB (Gore), Biointeractions, Medtronic, Surmodics, Corline, Toyobo, jMedtech, Biosurf
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antithrombogenic Heparin Coating manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antithrombogenic Heparin Coating in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Antithrombogenic Heparin Coating Market growing?

Ans: The Antithrombogenic Heparin Coating Market witnessing a CAGR of 9.2% during the forecast period 2025-2030.

What is the Antithrombogenic Heparin Coating Market size in 2030?

Ans: The Antithrombogenic Heparin Coating Market size in 2030 will be US$ 261 million.

Who are the main players in the Antithrombogenic Heparin Coating Market report?

Ans: The main players in the Antithrombogenic Heparin Coating Market are Carmeda AB (Gore), Biointeractions, Medtronic, Surmodics, Corline, Toyobo, jMedtech, Biosurf

What are the Application segmentation covered in the Antithrombogenic Heparin Coating Market report?

Ans: The Applications covered in the Antithrombogenic Heparin Coating Market report are Catheters, Stents, Implants, Others

What are the Type segmentation covered in the Antithrombogenic Heparin Coating Market report?

Ans: The Types covered in the Antithrombogenic Heparin Coating Market report are Covalently Bonded Coatings, Physisorption Coatings

Recommended Reports

Heparin & Anticoagulants

Medical Device Coatings

Hemostatic & Thromboresistant

1 Antithrombogenic Heparin Coating Market Overview
1.1 Product Definition
1.2 Antithrombogenic Heparin Coating by Type
1.2.1 Global Antithrombogenic Heparin Coating Market Value Comparison by Type (2024-2030)
1.2.2 Covalently Bonded Coatings
1.2.3 Physisorption Coatings
1.3 Antithrombogenic Heparin Coating by Application
1.3.1 Global Antithrombogenic Heparin Coating Market Value by Application (2024-2030)
1.3.2 Catheters
1.3.3 Stents
1.3.4 Implants
1.3.5 Others
1.4 Global Antithrombogenic Heparin Coating Market Size Estimates and Forecasts
1.4.1 Global Antithrombogenic Heparin Coating Revenue 2019-2030
1.4.2 Global Antithrombogenic Heparin Coating Sales 2019-2030
1.4.3 Global Antithrombogenic Heparin Coating Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antithrombogenic Heparin Coating Market Competition by Manufacturers
2.1 Global Antithrombogenic Heparin Coating Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antithrombogenic Heparin Coating Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antithrombogenic Heparin Coating Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Antithrombogenic Heparin Coating, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antithrombogenic Heparin Coating, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antithrombogenic Heparin Coating, Product Type & Application
2.7 Global Key Manufacturers of Antithrombogenic Heparin Coating, Date of Enter into This Industry
2.8 Global Antithrombogenic Heparin Coating Market Competitive Situation and Trends
2.8.1 Global Antithrombogenic Heparin Coating Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antithrombogenic Heparin Coating Players Market Share by Revenue
2.8.3 Global Antithrombogenic Heparin Coating Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antithrombogenic Heparin Coating Market Scenario by Region
3.1 Global Antithrombogenic Heparin Coating Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antithrombogenic Heparin Coating Sales by Region: 2019-2030
3.2.1 Global Antithrombogenic Heparin Coating Sales by Region: 2019-2024
3.2.2 Global Antithrombogenic Heparin Coating Sales by Region: 2025-2030
3.3 Global Antithrombogenic Heparin Coating Revenue by Region: 2019-2030
3.3.1 Global Antithrombogenic Heparin Coating Revenue by Region: 2019-2024
3.3.2 Global Antithrombogenic Heparin Coating Revenue by Region: 2025-2030
3.4 North America Antithrombogenic Heparin Coating Market Facts & Figures by Country
3.4.1 North America Antithrombogenic Heparin Coating Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antithrombogenic Heparin Coating Sales by Country (2019-2030)
3.4.3 North America Antithrombogenic Heparin Coating Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antithrombogenic Heparin Coating Market Facts & Figures by Country
3.5.1 Europe Antithrombogenic Heparin Coating Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antithrombogenic Heparin Coating Sales by Country (2019-2030)
3.5.3 Europe Antithrombogenic Heparin Coating Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antithrombogenic Heparin Coating Market Facts & Figures by Region
3.6.1 Asia Pacific Antithrombogenic Heparin Coating Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antithrombogenic Heparin Coating Sales by Region (2019-2030)
3.6.3 Asia Pacific Antithrombogenic Heparin Coating Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antithrombogenic Heparin Coating Market Facts & Figures by Country
3.7.1 Latin America Antithrombogenic Heparin Coating Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antithrombogenic Heparin Coating Sales by Country (2019-2030)
3.7.3 Latin America Antithrombogenic Heparin Coating Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Antithrombogenic Heparin Coating Market Facts & Figures by Country
3.8.1 Middle East and Africa Antithrombogenic Heparin Coating Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antithrombogenic Heparin Coating Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antithrombogenic Heparin Coating Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antithrombogenic Heparin Coating Sales by Type (2019-2030)
4.1.1 Global Antithrombogenic Heparin Coating Sales by Type (2019-2024)
4.1.2 Global Antithrombogenic Heparin Coating Sales by Type (2025-2030)
4.1.3 Global Antithrombogenic Heparin Coating Sales Market Share by Type (2019-2030)
4.2 Global Antithrombogenic Heparin Coating Revenue by Type (2019-2030)
4.2.1 Global Antithrombogenic Heparin Coating Revenue by Type (2019-2024)
4.2.2 Global Antithrombogenic Heparin Coating Revenue by Type (2025-2030)
4.2.3 Global Antithrombogenic Heparin Coating Revenue Market Share by Type (2019-2030)
4.3 Global Antithrombogenic Heparin Coating Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antithrombogenic Heparin Coating Sales by Application (2019-2030)
5.1.1 Global Antithrombogenic Heparin Coating Sales by Application (2019-2024)
5.1.2 Global Antithrombogenic Heparin Coating Sales by Application (2025-2030)
5.1.3 Global Antithrombogenic Heparin Coating Sales Market Share by Application (2019-2030)
5.2 Global Antithrombogenic Heparin Coating Revenue by Application (2019-2030)
5.2.1 Global Antithrombogenic Heparin Coating Revenue by Application (2019-2024)
5.2.2 Global Antithrombogenic Heparin Coating Revenue by Application (2025-2030)
5.2.3 Global Antithrombogenic Heparin Coating Revenue Market Share by Application (2019-2030)
5.3 Global Antithrombogenic Heparin Coating Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Carmeda AB (Gore)
6.1.1 Carmeda AB (Gore) Company Information
6.1.2 Carmeda AB (Gore) Description and Business Overview
6.1.3 Carmeda AB (Gore) Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Carmeda AB (Gore) Antithrombogenic Heparin Coating Product Portfolio
6.1.5 Carmeda AB (Gore) Recent Developments/Updates
6.2 Biointeractions
6.2.1 Biointeractions Company Information
6.2.2 Biointeractions Description and Business Overview
6.2.3 Biointeractions Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Biointeractions Antithrombogenic Heparin Coating Product Portfolio
6.2.5 Biointeractions Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Medtronic Antithrombogenic Heparin Coating Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Surmodics
6.4.1 Surmodics Company Information
6.4.2 Surmodics Description and Business Overview
6.4.3 Surmodics Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Surmodics Antithrombogenic Heparin Coating Product Portfolio
6.4.5 Surmodics Recent Developments/Updates
6.5 Corline
6.5.1 Corline Company Information
6.5.2 Corline Description and Business Overview
6.5.3 Corline Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Corline Antithrombogenic Heparin Coating Product Portfolio
6.5.5 Corline Recent Developments/Updates
6.6 Toyobo
6.6.1 Toyobo Company Information
6.6.2 Toyobo Description and Business Overview
6.6.3 Toyobo Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Toyobo Antithrombogenic Heparin Coating Product Portfolio
6.6.5 Toyobo Recent Developments/Updates
6.7 jMedtech
6.7.1 jMedtech Company Information
6.7.2 jMedtech Description and Business Overview
6.7.3 jMedtech Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.7.4 jMedtech Antithrombogenic Heparin Coating Product Portfolio
6.7.5 jMedtech Recent Developments/Updates
6.8 Biosurf
6.8.1 Biosurf Company Information
6.8.2 Biosurf Description and Business Overview
6.8.3 Biosurf Antithrombogenic Heparin Coating Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biosurf Antithrombogenic Heparin Coating Product Portfolio
6.8.5 Biosurf Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antithrombogenic Heparin Coating Industry Chain Analysis
7.2 Antithrombogenic Heparin Coating Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antithrombogenic Heparin Coating Production Mode & Process
7.4 Antithrombogenic Heparin Coating Sales and Marketing
7.4.1 Antithrombogenic Heparin Coating Sales Channels
7.4.2 Antithrombogenic Heparin Coating Distributors
7.5 Antithrombogenic Heparin Coating Customers
8 Antithrombogenic Heparin Coating Market Dynamics
8.1 Antithrombogenic Heparin Coating Industry Trends
8.2 Antithrombogenic Heparin Coating Market Drivers
8.3 Antithrombogenic Heparin Coating Market Challenges
8.4 Antithrombogenic Heparin Coating Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Antithrombogenic Heparin Coating Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Antithrombogenic Heparin Coating Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Antithrombogenic Heparin Coating Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Antithrombogenic Heparin Coating Sales (Tons) of Key Manufacturers (2019-2024)
 Table 5. Global Antithrombogenic Heparin Coating Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Antithrombogenic Heparin Coating Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Antithrombogenic Heparin Coating Average Price (US$/Kg) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Antithrombogenic Heparin Coating, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antithrombogenic Heparin Coating, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antithrombogenic Heparin Coating, Product Type & Application
 Table 12. Global Key Manufacturers of Antithrombogenic Heparin Coating, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antithrombogenic Heparin Coating by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithrombogenic Heparin Coating as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antithrombogenic Heparin Coating Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Antithrombogenic Heparin Coating Sales by Region (2019-2024) & (Tons)
 Table 18. Global Antithrombogenic Heparin Coating Sales Market Share by Region (2019-2024)
 Table 19. Global Antithrombogenic Heparin Coating Sales by Region (2025-2030) & (Tons)
 Table 20. Global Antithrombogenic Heparin Coating Sales Market Share by Region (2025-2030)
 Table 21. Global Antithrombogenic Heparin Coating Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Antithrombogenic Heparin Coating Revenue Market Share by Region (2019-2024)
 Table 23. Global Antithrombogenic Heparin Coating Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Antithrombogenic Heparin Coating Revenue Market Share by Region (2025-2030)
 Table 25. North America Antithrombogenic Heparin Coating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Antithrombogenic Heparin Coating Sales by Country (2019-2024) & (Tons)
 Table 27. North America Antithrombogenic Heparin Coating Sales by Country (2025-2030) & (Tons)
 Table 28. North America Antithrombogenic Heparin Coating Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Antithrombogenic Heparin Coating Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Antithrombogenic Heparin Coating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Antithrombogenic Heparin Coating Sales by Country (2019-2024) & (Tons)
 Table 32. Europe Antithrombogenic Heparin Coating Sales by Country (2025-2030) & (Tons)
 Table 33. Europe Antithrombogenic Heparin Coating Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Antithrombogenic Heparin Coating Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Antithrombogenic Heparin Coating Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Antithrombogenic Heparin Coating Sales by Region (2019-2024) & (Tons)
 Table 37. Asia Pacific Antithrombogenic Heparin Coating Sales by Region (2025-2030) & (Tons)
 Table 38. Asia Pacific Antithrombogenic Heparin Coating Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Antithrombogenic Heparin Coating Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Antithrombogenic Heparin Coating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Antithrombogenic Heparin Coating Sales by Country (2019-2024) & (Tons)
 Table 42. Latin America Antithrombogenic Heparin Coating Sales by Country (2025-2030) & (Tons)
 Table 43. Latin America Antithrombogenic Heparin Coating Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Antithrombogenic Heparin Coating Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Antithrombogenic Heparin Coating Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Antithrombogenic Heparin Coating Sales by Country (2019-2024) & (Tons)
 Table 47. Middle East and Africa Antithrombogenic Heparin Coating Sales by Country (2025-2030) & (Tons)
 Table 48. Middle East and Africa Antithrombogenic Heparin Coating Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Antithrombogenic Heparin Coating Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Antithrombogenic Heparin Coating Sales (Tons) by Type (2019-2024)
 Table 51. Global Antithrombogenic Heparin Coating Sales (Tons) by Type (2025-2030)
 Table 52. Global Antithrombogenic Heparin Coating Sales Market Share by Type (2019-2024)
 Table 53. Global Antithrombogenic Heparin Coating Sales Market Share by Type (2025-2030)
 Table 54. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Antithrombogenic Heparin Coating Revenue Market Share by Type (2019-2024)
 Table 57. Global Antithrombogenic Heparin Coating Revenue Market Share by Type (2025-2030)
 Table 58. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Type (2019-2024)
 Table 59. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Type (2025-2030)
 Table 60. Global Antithrombogenic Heparin Coating Sales (Tons) by Application (2019-2024)
 Table 61. Global Antithrombogenic Heparin Coating Sales (Tons) by Application (2025-2030)
 Table 62. Global Antithrombogenic Heparin Coating Sales Market Share by Application (2019-2024)
 Table 63. Global Antithrombogenic Heparin Coating Sales Market Share by Application (2025-2030)
 Table 64. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Antithrombogenic Heparin Coating Revenue Market Share by Application (2019-2024)
 Table 67. Global Antithrombogenic Heparin Coating Revenue Market Share by Application (2025-2030)
 Table 68. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Application (2019-2024)
 Table 69. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Application (2025-2030)
 Table 70. Carmeda AB (Gore) Company Information
 Table 71. Carmeda AB (Gore) Description and Business Overview
 Table 72. Carmeda AB (Gore) Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 73. Carmeda AB (Gore) Antithrombogenic Heparin Coating Product
 Table 74. Carmeda AB (Gore) Recent Developments/Updates
 Table 75. Biointeractions Company Information
 Table 76. Biointeractions Description and Business Overview
 Table 77. Biointeractions Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 78. Biointeractions Antithrombogenic Heparin Coating Product
 Table 79. Biointeractions Recent Developments/Updates
 Table 80. Medtronic Company Information
 Table 81. Medtronic Description and Business Overview
 Table 82. Medtronic Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 83. Medtronic Antithrombogenic Heparin Coating Product
 Table 84. Medtronic Recent Developments/Updates
 Table 85. Surmodics Company Information
 Table 86. Surmodics Description and Business Overview
 Table 87. Surmodics Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 88. Surmodics Antithrombogenic Heparin Coating Product
 Table 89. Surmodics Recent Developments/Updates
 Table 90. Corline Company Information
 Table 91. Corline Description and Business Overview
 Table 92. Corline Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 93. Corline Antithrombogenic Heparin Coating Product
 Table 94. Corline Recent Developments/Updates
 Table 95. Toyobo Company Information
 Table 96. Toyobo Description and Business Overview
 Table 97. Toyobo Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 98. Toyobo Antithrombogenic Heparin Coating Product
 Table 99. Toyobo Recent Developments/Updates
 Table 100. jMedtech Company Information
 Table 101. jMedtech Description and Business Overview
 Table 102. jMedtech Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 103. jMedtech Antithrombogenic Heparin Coating Product
 Table 104. jMedtech Recent Developments/Updates
 Table 105. Biosurf Company Information
 Table 106. Biosurf Description and Business Overview
 Table 107. Biosurf Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
 Table 108. Biosurf Antithrombogenic Heparin Coating Product
 Table 109. Biosurf Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Antithrombogenic Heparin Coating Distributors List
 Table 113. Antithrombogenic Heparin Coating Customers List
 Table 114. Antithrombogenic Heparin Coating Market Trends
 Table 115. Antithrombogenic Heparin Coating Market Drivers
 Table 116. Antithrombogenic Heparin Coating Market Challenges
 Table 117. Antithrombogenic Heparin Coating Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antithrombogenic Heparin Coating
 Figure 2. Global Antithrombogenic Heparin Coating Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Antithrombogenic Heparin Coating Market Share by Type: 2023 & 2030
 Figure 4. Covalently Bonded Coatings Product Picture
 Figure 5. Physisorption Coatings Product Picture
 Figure 6. Global Antithrombogenic Heparin Coating Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Antithrombogenic Heparin Coating Market Share by Application: 2023 & 2030
 Figure 8. Catheters
 Figure 9. Stents
 Figure 10. Implants
 Figure 11. Others
 Figure 12. Global Antithrombogenic Heparin Coating Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Antithrombogenic Heparin Coating Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Antithrombogenic Heparin Coating Sales (2019-2030) & (Tons)
 Figure 15. Global Antithrombogenic Heparin Coating Average Price (US$/Kg) & (2019-2030)
 Figure 16. Antithrombogenic Heparin Coating Report Years Considered
 Figure 17. Antithrombogenic Heparin Coating Sales Share by Manufacturers in 2023
 Figure 18. Global Antithrombogenic Heparin Coating Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Antithrombogenic Heparin Coating Players: Market Share by Revenue in Antithrombogenic Heparin Coating in 2023
 Figure 20. Antithrombogenic Heparin Coating Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Antithrombogenic Heparin Coating Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Antithrombogenic Heparin Coating Sales Market Share by Country (2019-2030)
 Figure 23. North America Antithrombogenic Heparin Coating Revenue Market Share by Country (2019-2030)
 Figure 24. United States Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Antithrombogenic Heparin Coating Sales Market Share by Country (2019-2030)
 Figure 27. Europe Antithrombogenic Heparin Coating Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Antithrombogenic Heparin Coating Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Antithrombogenic Heparin Coating Revenue Market Share by Region (2019-2030)
 Figure 35. China Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Antithrombogenic Heparin Coating Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Antithrombogenic Heparin Coating Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Antithrombogenic Heparin Coating Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Antithrombogenic Heparin Coating Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Antithrombogenic Heparin Coating by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Antithrombogenic Heparin Coating by Type (2019-2030)
 Figure 54. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Antithrombogenic Heparin Coating by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Antithrombogenic Heparin Coating by Application (2019-2030)
 Figure 57. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Application (2019-2030)
 Figure 58. Antithrombogenic Heparin Coating Value Chain
 Figure 59. Antithrombogenic Heparin Coating Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart